{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:37:32Z","timestamp":1766137052549,"version":"3.41.2"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tetracyclines for tularemia have been associated with higher failure rates. There were 48 cases of tularemia at the University of Missouri between 1988 and 2015. We retrospectively analyzed 17 patients with tularemia who were successfully treated with tetracyclines, and 9 of these patients also underwent aspiration or incision and drainage.<\/jats:p>","DOI":"10.1093\/ofid\/ofy176","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T16:41:15Z","timestamp":1536079275000},"source":"Crossref","is-referenced-by-count":12,"title":["Tetracyclines for Treatment of Tularemia: A Case Series"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-226X","authenticated-orcid":false,"given":"C","family":"Rojas-Moreno","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Bhartee","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Vasudevan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Adiga","sequence":"additional","affiliation":[{"name":"Liberty Hospital, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Salzer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"volume-title":"Tularemia","author":"Centers for Disease Control and Prevention","key":"2020081004294017600_CIT0001"},{"volume-title":"WHO Guidelines on Tularaemia","year":"2007","author":"World Health Organization","key":"2020081004294017600_CIT0002"},{"key":"2020081004294017600_CIT0003","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","article-title":"Tularemia as a biological weapon: medical and public health management","volume":"285","author":"Dennis","year":"2001","journal-title":"JAMA"},{"key":"2020081004294017600_CIT0004","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1086\/597261","article-title":"Molecular epidemiology of Francisella tularensis in the United States","volume":"48","author":"Kugeler","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020081004294017600_CIT0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jama.1946.02870070013004","article-title":"Streptomycin treatment of tularemia","volume":"130","author":"Foshay","year":"1946","journal-title":"J Am Med Assoc"},{"key":"2020081004294017600_CIT0006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/clinids\/19.1.42","article-title":"Streptomycin and alternative agents for the treatment of tularemia: review of the literature","volume":"19","author":"Enderlin","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2020081004294017600_CIT0007","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/MMBR.30.3.542-550.1966","article-title":"Antibiotic prophylaxis and therapy of airborne tularemia","volume":"30","author":"Sawyer","year":"1966","journal-title":"Bacteriol Rev"},{"key":"2020081004294017600_CIT0008","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cis706","article-title":"Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases","volume":"55","author":"Weber","year":"2012","journal-title":"Clin Infect Dis"},{"author":"Adiga","key":"2020081004294017600_CIT0009","article-title":"Efficacy of oral tetracyclines in treatment of tularemia [poster]"},{"key":"2020081004294017600_CIT0010","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1128\/AAC.44.12.3428-3431.2000","article-title":"Bactericidal activities of antibiotics against intracellular Francisella tularensis","volume":"44","author":"Maurin","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081004294017600_CIT0011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fcimb.2017.00122","article-title":"Francisella tularensis susceptibility to antibiotics: a comprehensive review of the data obtained in vitro and in animal models","volume":"7","author":"Caspar","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2020081004294017600_CIT0012","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/322601","article-title":"Tularemia epidemic in northwestern Spain: clinical description and therapeutic response","volume":"33","author":"P\u00e9rez-Castrill\u00f3n","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020081004294017600_CIT0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1086\/321825","article-title":"Ciprofloxacin for treatment of tularemia","volume":"33","author":"Johansson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020081004294017600_CIT0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0463.2008.00901.x","article-title":"Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia","volume":"116","author":"Meric","year":"2008","journal-title":"APMIS"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/9\/ofy176\/33575368\/ofy176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/9\/ofy176\/33575368\/ofy176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:33:34Z","timestamp":1597048414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy176\/5090675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofy176","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,9,1]]},"article-number":"ofy176"}}